Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 892574
                    [Title] => ‘PRESYON 3’ aims to improve blood pressure control in Phl
                    [Summary] => 
High blood pressure remains to be a growing health concern in the Philippines.

                    [DatePublished] => 2013-01-03 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => http://imageshack.us/a/img841/6591/scitec4newthumb.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 853257
                    [Title] => New pain treatment out
                    [Summary] => 
Invida Philippines, the local subsidiary of leading Italian research-based pharmaceutical group Menarini, has launched dexketoprofen trometamol, a novel molecule that promises rapid and efficacious pain relief with lesser gastrointestinal side effects due to its formulation.
                    [DatePublished] => 2012-09-27 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 838599
                    [Title] => Invida launches beta blocker with dual action for hypertension, heart failure
                    [Summary] => 
Invida Philippines, the local subsidiary of leading Italian research-based pharmaceutical group Menarini, has launched Nebivolol, a highly cardioselective beta blocker that effectively treats hypertension and congestive heart failure (CHF).
                    [DatePublished] => 2012-08-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

INVIDA PHILIPPINES INC

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 892574
                    [Title] => ‘PRESYON 3’ aims to improve blood pressure control in Phl
                    [Summary] => 
High blood pressure remains to be a growing health concern in the Philippines.

                    [DatePublished] => 2013-01-03 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => http://imageshack.us/a/img841/6591/scitec4newthumb.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 853257
                    [Title] => New pain treatment out
                    [Summary] => 
Invida Philippines, the local subsidiary of leading Italian research-based pharmaceutical group Menarini, has launched dexketoprofen trometamol, a novel molecule that promises rapid and efficacious pain relief with lesser gastrointestinal side effects due to its formulation.
                    [DatePublished] => 2012-09-27 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 838599
                    [Title] => Invida launches beta blocker with dual action for hypertension, heart failure
                    [Summary] => 
Invida Philippines, the local subsidiary of leading Italian research-based pharmaceutical group Menarini, has launched Nebivolol, a highly cardioselective beta blocker that effectively treats hypertension and congestive heart failure (CHF).
                    [DatePublished] => 2012-08-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

‘PRESYON 3’ aims to improve blood pressure control in Phl

January 3, 2013 - 12:00am

High blood pressure remains to be a growing health concern in the Philippines.

Science and Environment

New pain treatment out

September 27, 2012 - 12:00am

Invida Philippines, the local subsidiary of leading Italian research-based pharmaceutical group Menarini, has launched dexketoprofen trometamol, a novel molecule that promises rapid and efficacious pain relief with...

Science and Environment

Invida launches beta blocker with dual action for hypertension, heart failure

August 16, 2012 - 12:00am

Invida Philippines, the local subsidiary of leading Italian research-based pharmaceutical group Menarini, has launched Nebivolol, a highly cardioselective beta blocker that effectively treats hypertension and congestive...

Science and Environment